PAPER Ning Y, Zhang Y, Jiang T, Feng J, Zhan J, Ou C, Wang L
SEARCH RESULTS
5492 RESULTS
PAPER Chen Z, Jiang D, Kong Y, Zhang J, Min C, Bi S, Yan S, Ye H, Li J, Wang L, Lu J, Wu L
Association of Glymphatic Function With Clinical Characteristics in Patients With Clinical and Asymptomatic Creutzfeldt-Jakob Disease.
Neurology. 2025 Jan 14;104(1):e210055. Epub 2024 Dec 13 PubMed.PAPER Grill JD, Tam S, Thai G, Vides B, Pierce AL, Green K, Gillen DL, Teng E, Kremen S, Beigi M, Rissman RA, Léger GC, Balasubramanian A, Revta C, Morrison R, Jennings R, Pa J, Zhang J, Jin S, Messer K, Feldman HH
Phase 2A Proof-of-Concept Double-Blind, Randomized, Placebo-Controlled Trial of Nicotinamide in Early Alzheimer Disease.
Neurology. 2025 Jan 14;104(1):e210152. Epub 2024 Dec 13 PubMed.PAPER Saeed A, Waris A, Fuwad A, Iqbal J, Khan J, AlQahtani D, Gilani O, Shah UH, Alzheimer’s Disease Neuroimaging Initiative
Random survival forest model for early prediction of Alzheimer's disease conversion in early and late Mild cognitive impairment stages.
PLoS One. 2024;19(12):e0314725. Epub 2024 Dec 13 PubMed.PAPER Zhang Y, Ji C, Meng Y, He Y, Su X, Qin W, Zhang N
Altered neurovascular coupling in semantic variant primary progressive aphasia.
J Alzheimers Dis. 2024 Dec;102(3):830-840. Epub 2024 Oct 29 PubMed.PAPER Keith CM, Haut MW, Vieira Ligo Teixeira C, Mehta RI, Phelps H, Ward M, Miller M, Navia RO, Coleman MM, Marano G, Wang X, Pockl S, Rajabalee N, Scarisbrick DM, McCuddy WT, D'Haese PF, Rezai A, Wilhelmsen K
Memory consolidation, temporal and parietal atrophy, and metabolism in amyloid-β positive and negative mild cognitive impairment.
J Alzheimers Dis. 2024 Dec;102(3):778-791. Epub 2024 Oct 29 PubMed.PAPER Oliver A, Wildschut T, Redhead ES, Parker MO, Sharif S, Wood AP, Sedikides C, Cheston R
Benefits of nostalgic landmarks for people living with Alzheimer's disease.
J Alzheimers Dis. 2024 Dec;102(3):683-702. Epub 2024 Oct 29 PubMed.PAPER Ozdemir C, Olaimat MA, Bozdag S, Alzheimer’s Disease Neuroimaging Initiative
A Dynamic Model for Early Prediction of Alzheimer's Disease by Leveraging Graph Convolutional Networks and Tensor Algebra.
Pac Symp Biocomput. 2025;30:675-689. PubMed.PAPER Chandio BQ, Villalon-Reina JE, Nir TM, Thomopoulos SI, Feng Y, Benavidez S, Jahanshad N, Harezlak J, Garyfallidis E, Thompson PM, Alzheimer’s Disease Neuroimaging Initiative
Amyloid, Tau, and APOE in Alzheimer's Disease: Impact on White Matter Tracts.
Pac Symp Biocomput. 2025;30:394-411. PubMed.PAPER Singh K, Murti Y, Sharma AK, Dharamveer, Ved A, Yadav S, Kulshreshtha M
Pharmacological investigation of Achras sapota against scopolamine induce amnesia and cognitive impairment in laboratory animals.
Toxicol Rep. 2024 Dec;13:101813. Epub 2024 Nov 19 PubMed.PAPER Atay E, Bahadır Yılmaz E
The effect of cognitive stimulation therapy (CST) on apathy, loneliness, anxiety and activities of daily living in older people with Alzheimer's disease: randomized control study.
Aging Ment Health. 2024 Dec 13;:1-9. Epub 2024 Dec 13 PubMed.PAPER Manfredi JN, Gupta SK, Vyavahare S, Deak F, Lu X, Buddha L, Wankhade U, Lohakare J, Isales C, Fulzele S
Gut microbiota dysbiosis in Alzheimer's disease (AD): Insights from human clinical studies and the mouse AD models.
Physiol Behav. 2025 Mar 1;290:114778. Epub 2024 Dec 11 PubMed.PAPER Franklin Z, Hull C, Delibegovic M, Platt B
Pharmacological PTP1B inhibition rescues motor learning, neuroinflammation, and hyperglycaemia in a mouse model of Alzheimer's disease.
Exp Neurol. 2025 Mar;385:115115. Epub 2024 Dec 11 PubMed.PAPER Forrest SL, Kovacs GG
Current concepts and molecular pathology of neurodegenerative diseases.
Pathology. 2025 Mar;57(2):178-190. Epub 2024 Nov 14 PubMed.PAPER Hanazawa R, Sato H, Hirakawa A, Alzheimer’s Disease Neuroimaging Initiative
Mixture Disease Progression Model to Predict and Cluster the Long-Term Trajectory of Cognitive Decline in Alzheimer's Disease.
Ther Innov Regul Sci. 2025 Mar;59(2):264-277. Epub 2024 Dec 13 PubMed.Current Filters
- Date Range : Past 90 Days x